LncRNA-Disease Association Prediction Using Two-Side Sparse Self-Representation

Evidences increasingly indicate the involvement of long non-coding RNAs (lncRNAs) in various biological processes. As the mutations and abnormalities of lncRNAs are closely related to the progression of complex diseases, the identification of lncRNA-disease associations has become an important step toward the understanding and treatment of diseases. Since only a limited number of lncRNA-disease associations have been validated, an increasing number of computational approaches have been developed for predicting potential lncRNA-disease associations. However, how to predict potential associations precisely through computational approaches remains challenging. In this study, we propose a novel two-side sparse self-representation (TSSR) algorithm for lncRNA-disease association prediction. By learning the self-representations of lncRNAs and diseases from known lncRNA-disease associations adaptively, and leveraging the information provided by known lncRNA-disease associations and the intra-associations among lncRNAs and diseases derived from other existing databases, our model could effectively utilize the estimated representations of lncRNAs and diseases to predict potential lncRNA-disease associations. The experiment results on three real data sets demonstrate that our TSSR outperforms other competing methods significantly. Moreover, to further evaluate the effectiveness of TSSR in predicting potential lncRNAs-disease associations, case studies of Melanoma, Glioblastoma, and Glioma are carried out in this paper. The results demonstrate that TSSR can effectively identify some candidate lncRNAs associated with these three diseases.

[1]  Deeksha Bhartiya,et al.  Conceptual approaches for lncRNA drug discovery and future strategies , 2012, Expert opinion on drug discovery.

[2]  Bin Xu,et al.  Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22 , 2016, Oncotarget.

[3]  Yoshua Bengio,et al.  Random Search for Hyper-Parameter Optimization , 2012, J. Mach. Learn. Res..

[4]  J. Yuan,et al.  Induction effect of MicroRNA-449a on glioma cell proliferation and inhibition on glioma cell apoptosis by promoting PKCα. , 2015, European review for medical and pharmacological sciences.

[5]  Nicholas T. Ingolia,et al.  Ribosome Profiling Provides Evidence that Large Noncoding RNAs Do Not Encode Proteins , 2013, Cell.

[6]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[7]  Chee Keong Kwoh,et al.  Drug-target interaction prediction by learning from local information and neighbors , 2013, Bioinform..

[8]  Elena Marchiori,et al.  Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..

[9]  M. Symons,et al.  Signaling determinants of glioma cell invasion. , 2013, Advances in experimental medicine and biology.

[10]  Hao Ding,et al.  Collaborative matrix factorization with multiple similarities for predicting drug-target interactions , 2013, KDD.

[11]  Erkki Oja,et al.  Unified Development of Multiplicative Algorithms for Linear and Quadratic Nonnegative Matrix Factorization , 2011, IEEE Transactions on Neural Networks.

[12]  Qionghai Dai,et al.  Constructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarity , 2015, Scientific Reports.

[13]  Xing Chen,et al.  PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction , 2017, PLoS Comput. Biol..

[14]  Jiancheng Luo,et al.  Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications , 2014, Scientific Reports.

[15]  Yi Pan,et al.  Prediction of lncRNA–disease associations based on inductive matrix completion , 2018, Bioinform..

[16]  L. Lanfrancone,et al.  Molecular networks in melanoma invasion and metastasis. , 2013, Future oncology.

[17]  Xing Chen,et al.  FMLNCSIM: fuzzy measure-based lncRNA functional similarity calculation model , 2016, Oncotarget.

[18]  O. Gallego,et al.  Nonsurgical treatment of recurrent glioblastoma. , 2015, Current oncology.

[19]  W. Isaacs,et al.  DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. , 1999, Cancer research.

[20]  Xiaobo Zhou,et al.  Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces , 2010, BMC Systems Biology.

[21]  Y. Wang,et al.  Mammalian ncRNA-disease repository: a global view of ncRNA-mediated disease network , 2013, Cell Death and Disease.

[22]  Lei Zhao,et al.  Effect of long non-coding RNA PVT1 on cell proliferation and migration in melanoma , 2017, International journal of molecular medicine.

[23]  R. Barnard The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.

[24]  J. Mattick,et al.  Long Noncoding RNAs in Cardiac Development and Pathophysiology , 2012, Circulation research.

[25]  R. Jenkins,et al.  Genetics of adult glioma. , 2012, Cancer genetics.

[26]  Yu Zhou,et al.  LncRNA MEG3 repressed malignant melanoma progression via inactivating Wnt signaling pathway , 2018, Journal of cellular biochemistry.

[27]  Yu Cheng,et al.  lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients , 2017, Oncotarget.

[28]  David G. Knowles,et al.  The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.

[29]  Steven D. Brown,et al.  ICRM-2011 international chemometrics research meeting , 2012 .

[30]  Martin Klein,et al.  Psychiatric symptoms in glioma patients: from diagnosis to management , 2015, Neuropsychiatric disease and treatment.

[31]  Xuegong Zhang,et al.  Computational prediction of associations between long non-coding RNAs and proteins , 2013, BMC Genomics.

[32]  Tao Jiang,et al.  HOTAIR is a therapeutic target in glioblastoma , 2015, Oncotarget.

[33]  Howard Y. Chang,et al.  Long noncoding RNAs and human disease. , 2011, Trends in cell biology.

[34]  Nina Kočevar,et al.  Glioma and glioblastoma - how much do we (not) know? , 2013, Molecular and clinical oncology.

[35]  David Zhang,et al.  A Survey of Sparse Representation: Algorithms and Applications , 2015, IEEE Access.

[36]  Z. Xuan,et al.  Long Non-Coding RNAs and Complex Human Diseases , 2013, International journal of molecular sciences.

[37]  Zhu-Hong You,et al.  PRMDA: personalized recommendation-based MiRNA-disease association prediction , 2017, Oncotarget.

[38]  Erkki Oja,et al.  Clustering by Low-Rank Doubly Stochastic Matrix Decomposition , 2012, ICML.

[39]  Lei Wang,et al.  A Novel Method for LncRNA-Disease Association Prediction Based on an lncRNA-Disease Association Network , 2019, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[40]  Jing Quan,et al.  lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis. , 2018, Gene.

[41]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[42]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[43]  G. Su,et al.  Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma , 2015, Tumor Biology.

[44]  Xing Chen,et al.  LncRNADisease: a database for long-non-coding RNA-associated diseases , 2012, Nucleic Acids Res..

[45]  Lei Wang,et al.  A Novel Probability Model for LncRNA–Disease Association Prediction Based on the Naïve Bayesian Classifier , 2018, Genes.

[46]  J. Liu,et al.  Effect of downregulated lncRNA NBAT1 on the biological behavior of glioblastoma cells. , 2018, European Review for Medical and Pharmacological Sciences.

[47]  Xing Chen,et al.  Novel human lncRNA-disease association inference based on lncRNA expression profiles , 2013, Bioinform..

[48]  S. Leenstra,et al.  Recent advances in the molecular understanding of glioblastoma , 2009 .

[49]  Xing Chen,et al.  Long non-coding RNAs and complex diseases: from experimental results to computational models , 2016, Briefings Bioinform..

[50]  Peng Wang,et al.  Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers , 2015, Nucleic Acids Res..

[51]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[52]  Svetlana A. Shabalina,et al.  Negative Correlation between Expression Level and Evolutionary Rate of Long Intergenic Noncoding RNAs , 2011, Genome biology and evolution.

[53]  D. Louis WHO classification of tumours of the central nervous system , 2007 .

[54]  J. Mattick,et al.  Non‐coding RNAs: regulators of disease , 2010, The Journal of pathology.

[55]  Dapeng Hao,et al.  Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network. , 2015, Molecular bioSystems.

[56]  M. Gerstenblith,et al.  Ultraviolet radiation and melanoma. , 2011, Seminars in cutaneous medicine and surgery.